高级检索
    陈逗逗, 郑旭琴, 刘坤钰. 胰岛体内成像技术的进展[J]. 徐州医科大学学报, 2020, 40(4): 309-312.
    引用本文: 陈逗逗, 郑旭琴, 刘坤钰. 胰岛体内成像技术的进展[J]. 徐州医科大学学报, 2020, 40(4): 309-312.
    The progress of pancreatic islets in vivo imaging[J]. Journal of Xuzhou Medical University, 2020, 40(4): 309-312.
    Citation: The progress of pancreatic islets in vivo imaging[J]. Journal of Xuzhou Medical University, 2020, 40(4): 309-312.

    胰岛体内成像技术的进展

    The progress of pancreatic islets in vivo imaging

    • 摘要: 糖尿病是由于胰岛素分泌的绝对缺乏或相对缺乏引起的以血糖升高为特征的代谢病。胰岛素是由胰岛细胞中的β细胞所分泌,在降低血糖的同时具有促进糖原、脂肪、蛋白质合成作用。动物实验通过组织病理切片显示,某些新型降糖药或胰岛移植可通过增加胰岛β细胞数量促使胰岛素分泌增加,但在人体临床试验中,无法用有创性方法获取胰腺组织切片,因此如何开发无创性成像技术精确评估体内胰岛β细胞数量成为了研究的热点。本文将多种追踪胰岛β细胞成像的技术进行了汇总。

       

      Abstract: Diabetes is a me<x>tabolic disease characterized by hyperglycemia resulting from an absolute or relative deficiency of insulin produced by beta cells. Insulin -producing beta-cells promotes glycogen, fat, and protein synthesis while decreasing blood glucose. Section histopathological getting from animal experiment study indicate hypoglycemic agents or islet transplantation may promotes β-cell mass expansion and increase insulin secretion. In human clinical trials, invasive methods to obtain pancreatic tissue sections were impossible. Therefore,to develop non-invasive imaging technology for accurately estimating β- cells mass in vivo has become a research focus. In this review, a variety of techniques for tracking and imaging islet beta cells are summarized.

       

    /

    返回文章
    返回